glp 1 agonist clinical trials Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog GLP-1 receptor agonists and cardiovascular
Description
The cardiovascular outcome trials for the new obesity pharmacotherapies will help us understand better the long-term benefits and risks with each molecule
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
Cefalu WT, Kaul S, Gerstein HC, et al
Finally, sex assigned at birth was not assessed in this review work
Efficacy and safety of Glucagon-Like Peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis
45 However, the extent to which these benefits reflect weight loss vs
